Literature DB >> 11437199

Predicting return to work after brain injury using occupational therapy assessments.

U Johansson1, B Bernspång.   

Abstract

PURPOSE: The aim of this study was to evaluate the value of occupational therapy assessments used in an outreach rehabilitation programme to predict return to work after brain injury. The assessments represent the ICIDH-2 levels of body function and activity.
METHOD: Fifty-six persons in a late phase after brain injury who had been admitted to the rehabilitation programme during 2 years were followed up according to work status. The follow up was made at a minimum of 2 years after injury. Demographic data and scores from the occupational therapy assessments were compared for the two groups who were back to work or studies (BTW) and not back to work or studies (NBTW).
RESULTS: Assessments of memory, visual perception and apraxia separated between the two groups BTW and NBTW. Logistic regression showed that memory score in combination with data on PADL made up the best predictive model. In a subgroup with 21 persons where data on IADL were added to memory and PADL the predictive value was even stronger.
CONCLUSIONS: In this study we found that occupational therapy assessments were valuable in predicting failure to return to work or studies after brain injury.

Entities:  

Mesh:

Year:  2001        PMID: 11437199     DOI: 10.1080/09638280010010688

Source DB:  PubMed          Journal:  Disabil Rehabil        ISSN: 0963-8288            Impact factor:   3.033


  2 in total

Review 1.  An integrated review of the processes and factors relevant to vocational evaluation following traumatic brain injury.

Authors:  Mary Stergiou-Kita; Deirdre R Dawson; Susan G Rappolt
Journal:  J Occup Rehabil       Date:  2011-09

2.  The protocol and design of a randomised controlled study on training of attention within the first year after acquired brain injury.

Authors:  Aniko Bartfai; Gabriela Markovic; Kristina Sargenius Landahl; Marie-Louise Schult
Journal:  BMC Neurol       Date:  2014-05-08       Impact factor: 2.474

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.